CVS HEALTH Corp — Director's Dealing 2021

Dec 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-11-28

Reporting Person: Lynch Karen S (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-28	Common Stock	F	14121	$91.52	Disposed	69114	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock (By Trust)	94369	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Appreciation Rights	$45.91	2027-02-16	Common Stock (192741)	192741	Direct
Stock Appreciation Rights	$37.91	2026-02-18	Common Stock (93989)	93989	Direct
Stock Option	$54.19	2029-04-01	Common Stock (242408)	242408	Direct
Stock Option	$58.34	2030-04-01	Common Stock (211196)	211196	Direct
Stock Option	$74.30	2031-04-01	Common Stock (224604)	224604	Direct

Footnotes

F1: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award.

F2: Represents unvested Aetna Inc. Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Aetna Plan") on February 17, 2017 that were converted into CVS Health SARs pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vested in two substantially equal annual installments beginning on February 17, 2019.

F3: Represents unvested SARs granted under the Aetna Plan on February 19, 2016 that were converted into CVS Health SARs pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vested on February 19, 2019.

F4: Option became exercisable in four equal annual installments, commencing 4/1/2020.

F5: The number of shares subject to the option were calculated using a 30-day average price.

F6: Options became exercisable in four equal installments, commencing 4/1/2021.

F7: Option becomes exercisable in four equal installments, commencing 4/1/2022.